EDUC-BPD: Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for BPD Patients

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT05428462
Collaborator
(none)
50
1
8
6.3

Study Details

Study Description

Brief Summary

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.

Condition or Disease Intervention/Treatment Phase
  • Other: Psychoeducation day on borderline personality disorder

Detailed Description

Borderline personality disorder defined as "a pattern of instability in interpersonal relationships, self-image and affects, and impulsiveness marked" concerns 4-6% of the general population. This is the emotional trouble the most associated with the occurence of suicide attempts (85% of these patients make multiple suicide attempts) and death by suicide (10% of these patients). This is a major public health problem.

A large number of patients with borderline personality disorder are not informed of their diagnosis. The main reasons are : the non-recognition of this disorder by health professionals, the belief that borderline personality disorder is a overly stigmatizing diagnosis , or preference to diagnose another disorder - that professionals think respond better to treatments and therefore be of a better prognosis.

Patients with borderline personality disorder often think themselves as "bad people" or the only people suffering from these symptoms. Thus, the ignorance of borderline personality disorder by patients leads to a basis of their altered sense of identity, perceived as defective or isolated. This generate a strong internalized stigma.

Many people diagnosed with borderline personality disorder receive no information about this disorder while psychoeducation has shown its effectiveness in severe psychiatric disorders, including the disorder of borderline personality, by reducing the negative repercussions psychiatric pathology. Moreover, the education of patients suffering from self-stigma makes it possible to in the face of negative beliefs around the disease and the acquisition of knowledge about the disorder and how to deal with it reduces self-stigma in bipolar patients. However, the propensity to feel shame - the stigmatization of oneself as worthless - is strongest in borderline personality disorder compared to all psychiatric disorders and most associated with the occurence of suicidal behaviors. In recommendations with good clinical practice, the investigator propose within the sector a day of education on borderline personality disorder including a transmission of current scientific knowledge on the illness, a dimensional understanding of the disorder, and the dis-identification of self to the symptoms of borderline personality disorder. The investigator hypothesize that this day of psychoeducation makes it possible to decrease self-stigma, which could be a mediator in reducing negative repercussions of borderline pathology.

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for Borderline Personality Disorder (BPD) Patients
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Jan 1, 2021
Actual Study Completion Date :
Sep 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Comparison of internalized stigma of mental illnessillness [At immediate post-intervention]

    Comparison of internalized stigma of mental illness between pre-treatment

  2. Comparison of internalized stigma of mentalillness [At 3 months post-intervention]

    Comparison of internalized stigma of mental illness between pre-treatment

Secondary Outcome Measures

  1. Depressive symptoms using the Beck Depression Inventory [At immediate post-intervention]

    Comparison of depressive symptoms between pre-treatment and post-intervention

  2. Depressive symptoms using the Beck Depression Inventory [At 3 months post-intervention]

    Comparison of depressive symptoms between pre-treatment and 3 months post-intervention

  3. Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) [At immediate post-intervention]

    Comparison of the intensity of suicidal ideation between pre-treatment and post-intervention

  4. Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) [At 3 months post-intervention]

    Comparison of the intensity of suicidal ideation between pre-treatment and 3 months post-intervention

  5. Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) [At immediate post-intervention]

    Comparison of psychological pain between pre-treatment and post-intervention

  6. Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) [At 3 months post-intervention]

    Comparison of psychological pain between pre-treatment and 3 months post-intervention

  7. The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness) [At immediate post-intervention]

    Comparison of the intensity of hopelessness between pre-treatment and post-intervention

  8. The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness) [At 3 months post-intervention]

    Comparison of the intensity of hopelessness between pre-treatment and 3 months post-intervention

  9. The intensity of optimism using analog visual scale [At immediate post-intervention]

    Comparison of the intensity of optimism between pre-treatment and post-intervention

  10. The intensity of optimism using analog visual scale [At 3 months post-intervention]

    Comparison of the intensity of optimism between pre-treatment and 3 months post-intervention

  11. Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction [At immediate post-intervention]

    Comparison of feeling of pleasure between pre-treatment and post-intervention

  12. Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction [At 3 months post-intervention]

    Comparison of feeling of pleasure between pre-treatment and 3 months post-intervention

  13. Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction [At immediate post-intervention]

    Comparison of feeling of satisfaction between pre-treatment and post-intervention

  14. Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction [At 3 months post-intervention]

    Comparison of feeling of satisfaction between pre-treatment and 3 months post-intervention

  15. Anxiety state using the State-Trait Inventory (STAI-State) [At immediate post-intervention]

    Comparison of the state of anxiety between pre-treatment and post-intervention

  16. Anxiety state using the State-Trait Inventory (STAI-State) [At 3 months post-intervention]

    Comparison of the state of anxiety between pre-treatment and 3 months post-intervention

  17. Hopelessness using the Beck Hopelessness Scale (BHS) [At immediate post-intervention]

    Comparison of the hopelessness between pre-treatment and post-intervention

  18. Hopelessness using the Beck Hopelessness Scale (BHS) [At 3 months post-intervention]

    Comparison of the hopelessness between pre-treatment and 3 months post-intervention

  19. Level of positive and negative affects using the PANAS Scale [At immediate post-intervention]

    Comparison of level of positive and negative affects between pre-treatment and post-intervention

  20. Level of positive and negative affects using the PANAS Scale [At 3 months post-intervention]

    Comparison of level of positive and negative affects between pre-treatment and 3 months post-intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with Borderline Personality disorder assessed according to SCID II

  • Having attended the borderline education day

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Montpellier France 34000

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT05428462
Other Study ID Numbers:
  • RECHMPL21_0611
First Posted:
Jun 23, 2022
Last Update Posted:
Jul 5, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 5, 2022